Enadenotucirev
Enadenotucirev Uses, Dosage, Side Effects, Food Interaction and all others data.
Enadenotucirev is under investigation in clinical trial NCT02636036 (Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors).
| Trade Name | Enadenotucirev |
| Generic | Enadenotucirev |
| Enadenotucirev Other Names | Enadenotucirev |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Enadenotucirev
